EFDID: 104368EFD: View Filing

Issuer: PROVECTUS BIOPHARMACEUTICALS, INC. (0000315545) - D

Accession: 0000315545-14-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0000315545
  • Entity Name:
    PROVECTUS BIOPHARMACEUTICALS, INC.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    7327 OAK RIDGE HWY
    SUITE A
    KNOXVILLE, TN 37931
  • Persons:
    Related Persons 7
    Peter R. Culpepper
    Executive Officer 
    CFO, COO, CAO
    Alfred E. Smith IV
    Director
    Kelly M. McMasters
    Director
    H. Craig Dees
    Executive Officer, Director 
    CEO
    Jan Koe
    Director
    Eric A. Wachter
    Executive Officer 
    Chief Technology Officer
    Tim Scott
    Executive Officer 
    President
EDGAR: Offering Information
  • Accession Date:
    10/14/2014
  • First Sale Date:
  • Offering Amount:
    $15,000,000
  • Amount Sold:
    $0
  • Amount Remaining:
    $15,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
  • Sales Clarification:
    Sales in the offering will be staged incrementally at the sole discretion of the Company.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Network 1 Financial Securities, Inc. 13577 None None IL, NY, VA, CT, OH, TX, FL
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
PROVECTUS BIOPHARMACEUTICALS, INC./s/ Peter R. CulpepperPeter R. CulpepperCFO, COO & CAO2014-10-14